#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Inclusion body myositis Cholestatic pruritus Fms-like tyrosine kinase 3 positive Restless legs syndrome Congenital disorder of glycosylation Hereditary angioedema with C1 esterase inhibitor deficiency Spinal cord injury Mucous membrane pemphigoid Acute myeloid leukaemia Demyelination Sickle cell disease Narcolepsy Squamous cell carcinoma of the cervix Herpes simplex Oesophageal adenocarcinoma stage III More trials…

    Learn about Rare Diseases

    Advanced systemic mastocytosis – Diagnostics Pulmonary fibrosis – Diagnostics Mantle cell lymphoma stage II – Diagnostics Thrombotic thrombocytopenic purpura – Diagnostics Aicardi-Goutieres syndrome – Diagnostics Synovial sarcoma metastatic – Trials in Disease Metachromatic leukodystrophy Marginal zone lymphoma refractory – Diagnostics Hereditary motor and sensory neuropathy – Diagnostics Tuberous sclerosis complex – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Zopiclone Ceralasertib Ambrisentan Raludotatug Deruxtecan Mps-103 Clobetasol Propionate Cefuroxime Sodium Idecabtagene Vicleucel Hst-1011 Ammonium Chloride Bp Aminocaproic Acid Budigalimab Levomepromazine Hydrochloride Diclofenac Epolamine IDOR-1117-2520C Selexipag Pegargiminase Risdiplam Thiocolchicoside Bempikibart More therapies…

    Learn about Your Condition

    Noonan syndrome Hereditary ataxia Osteopenia Hepatitis alcoholic Dry mouth Constipation Behcet's syndrome Monogenic diabetes Radiation skin injury Bile duct adenocarcinoma Bone hypertrophy Acute kidney injury K-ras gene mutation Sarcoma metastatic Endocarditis enterococcal More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Sodium Valproate and Lenvatinib in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Sodium Valproate
    • Lenvatinib
    Italy

  • Premedication with dexamethasone to prevent interstitial lung disease in breast cancer patients receiving trastuzumab deruxtecan

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Dexamethasone
    Italy

  • Patient‑controlled propofol versus alfentanil and midazolam sedation for adenoma patients undergoing diagnostic and therapeutic colonoscopy: a satisfaction study

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Propofol
    • Midazolam
    Sweden

  • A Phase 2 Study of Aganirsen Eye Drops to Extend Intravitreal Aflibercept Injection Interval in Patients with Wet Age‑Related Macular Degeneration

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Neovascular age-related macular degeneration
    Investigated Drugs:
    • AGANIRSEN
    • Aflibercept
    France

  • Tezepelumab Effects on TSLP Protein Induction in Adults with Severe Asthma, With and Without Chronic Rhinosinusitis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Tezepelumab
    Denmark

  • Flecainide versus Bisoprolol as First-Line Treatment for Premature Ventricular Contractions in Adult Patients: A Multicenter Randomized Trial

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Ventricular extrasystoles
    Investigated Drugs:
    • Bisoprolol
    • Flecainide
    France
Previous Page
1 … 665 666 667 668 669 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!